Germany
Orbem, founded in 2019, is pioneering the industrialization of MRI technology through AI. Their innovative approach transforms daunting biological data into actionable intelligence, serving the agriculture, food, and health sectors. By providing insights into previously inaccessible data, such as embryo sex within an egg or the internal quality of an avocado, Orbem helps reduce waste, improve quality, and promote sustainability.
Headquartered in Germany with a presence in Houston, Orbem's unique technology drives better decision-making among food producers, researchers, and innovators, fostering a healthier future.
Supported by a robust investment infrastructure, Orbem secured a €55.50M Series B investment in January 2026 from notable partners, including The Venture Collective (TVC), 83North, General Catalyst, Possible Ventures, Supernova Invest, and Innovation Industries. This significant financial backing underscores the confidence in Orbem's capacity to reshape the industry's view on biological matter.
